+924.9%
MRNA vs CGNX
+19.2%
+905.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CGNX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -10.5% | +3.9% | -6.9% |
| 7D | +8.4% | -19.5% | +27.8% | +7.4% |
| 30D | +28.8% | -28.4% | +57.2% | +26.0% |
| 3M | +329.2% | -32.7% | +362.0% | +331.3% |
| 6M | +416.9% | -19.0% | +436.0% | +397.0% |
| YTD | +718.8% | +32.6% | +686.2% | +570.6% |
| 1Y | +924.9% | +18.0% | +906.8% | +815.6% |
| All | +924.9% | +19.2% | +905.7% | +815.6% |
Cumulative growth
Daily Returns
Daily percentage return beside CGNX.
Daily Out/Under-Performance
Portfolio return minus CGNX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CGNX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CGNX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling